Edwards Lifesciences Price to Book Ratio 2012-2025 | EW
Historical price to book ratio values for Edwards Lifesciences (EW) over the last 10 years. The current price to book ratio for Edwards Lifesciences as of February 06, 2026 is 4.53.
| Edwards Lifesciences Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-02-06 | 78.71 | 4.48 | |
| 2025-09-30 | 77.77 | $17.57 | 4.43 |
| 2025-06-30 | 78.21 | $18.04 | 4.34 |
| 2025-03-31 | 72.48 | $17.39 | 4.17 |
| 2024-12-31 | 74.03 | $17.10 | 4.33 |
| 2024-09-30 | 65.99 | $16.30 | 4.05 |
| 2024-06-30 | 92.37 | $12.46 | 7.41 |
| 2024-03-31 | 95.56 | $11.93 | 8.01 |
| 2023-12-31 | 76.25 | $11.18 | 6.82 |
| 2023-09-30 | 69.28 | $11.09 | 6.25 |
| 2023-06-30 | 94.33 | $10.60 | 8.90 |
| 2023-03-31 | 82.73 | $10.00 | 8.27 |
| 2022-12-31 | 74.61 | $9.55 | 7.82 |
| 2022-09-30 | 82.63 | $10.04 | 8.23 |
| 2022-06-30 | 95.09 | $9.59 | 9.92 |
| 2022-03-31 | 117.72 | $9.41 | 12.52 |
| 2021-12-31 | 129.55 | $9.35 | 13.85 |
| 2021-09-30 | 113.21 | $8.88 | 12.75 |
| 2021-06-30 | 103.57 | $8.24 | 12.57 |
| 2021-03-31 | 83.64 | $7.49 | 11.16 |
| 2020-12-31 | 91.23 | $7.33 | 12.45 |
| 2020-09-30 | 79.82 | $6.76 | 11.81 |
| 2020-06-30 | 69.11 | $6.18 | 11.19 |
| 2020-03-31 | 62.87 | $6.30 | 9.98 |
| 2019-12-31 | 77.76 | $19.84 | 3.92 |
| 2019-09-30 | 73.30 | $6.10 | 12.02 |
| 2019-06-30 | 61.58 | $5.61 | 10.97 |
| 2019-03-31 | 63.78 | $5.51 | 11.57 |
| 2018-12-31 | 51.06 | $5.04 | 10.13 |
| 2018-09-30 | 58.03 | $5.36 | 10.83 |
| 2018-06-30 | 48.52 | $5.04 | 9.62 |
| 2018-03-31 | 46.51 | $5.13 | 9.06 |
| 2017-12-31 | 37.57 | $4.70 | 8.00 |
| 2017-09-30 | 36.44 | $4.98 | 7.31 |
| 2017-06-30 | 39.41 | $4.64 | 8.49 |
| 2017-03-31 | 31.36 | $4.35 | 7.22 |
| 2016-12-31 | 31.23 | $4.13 | 7.57 |
| 2016-09-30 | 40.19 | $4.20 | 9.57 |
| 2016-06-30 | 33.24 | $3.87 | 8.58 |
| 2016-03-31 | 29.40 | $3.62 | 8.13 |
| 2015-12-31 | 26.33 | $3.87 | 6.80 |
| 2015-09-30 | 23.70 | $3.75 | 6.32 |
| 2015-06-30 | 23.74 | $3.55 | 6.68 |
| 2015-03-31 | 23.74 | $3.43 | 6.92 |
| 2014-12-31 | 21.23 | $6.78 | 3.13 |
| 2014-09-30 | 17.03 | $3.19 | 5.34 |
| 2014-06-30 | 14.31 | $3.01 | 4.75 |
| 2014-03-31 | 12.36 | $2.12 | 5.82 |
| 2013-12-31 | 10.96 | $2.36 | 4.65 |
| 2013-09-30 | 11.61 | $2.19 | 5.30 |
| 2013-06-30 | 11.20 | $2.35 | 4.77 |
| 2013-03-31 | 13.69 | $2.34 | 5.86 |
| 2012-12-31 | 15.03 | $2.16 | 6.97 |
| 2012-09-30 | 17.90 | $2.21 | 8.11 |
| 2012-06-30 | 17.22 | $2.07 | 8.30 |
| 2012-03-31 | 12.12 | $2.03 | 5.96 |
| 2011-12-31 | 11.78 | $1.95 | 6.03 |
| 2011-09-30 | 11.88 | $1.98 | 6.01 |
| 2011-06-30 | 14.53 | $2.01 | 7.23 |
| 2011-03-31 | 14.50 | $1.97 | 7.36 |
| 2010-12-31 | 13.47 | $1.90 | 7.11 |
| 2010-09-30 | 11.18 | $1.80 | 6.20 |
| 2010-06-30 | 9.34 | $1.65 | 5.67 |
| 2010-03-31 | 8.24 | $1.69 | 4.88 |
| 2009-12-31 | 7.24 | $3.40 | 2.13 |
| 2009-09-30 | 5.83 | $1.61 | 3.62 |
| 2009-06-30 | 5.67 | $1.48 | 3.83 |
| 2009-03-31 | 5.05 | $1.40 | 3.60 |
| 2008-12-31 | 4.58 | $1.31 | 3.50 |
| 2008-09-30 | 4.81 | $1.30 | 3.69 |
| 2008-06-30 | 5.17 | $1.32 | 3.91 |
| 2008-03-31 | 3.71 | $1.19 | 3.13 |
| 2007-12-31 | 3.83 | $1.23 | 3.12 |
| 2007-09-30 | 4.11 | $1.21 | 3.41 |
| 2007-06-30 | 4.11 | $1.17 | 3.51 |
| 2007-03-31 | 4.23 | $1.13 | 3.73 |
| 2006-12-31 | 3.92 | $1.08 | 3.62 |
| 2006-09-30 | 3.88 | $1.05 | 3.70 |
| 2006-06-30 | 3.79 | $1.03 | 3.67 |
| 2006-03-31 | 3.63 | $1.02 | 3.56 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $45.675B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $203.946B | 23.74 |
| Intuitive Surgical (ISRG) | United States | $173.357B | 66.87 |
| IDEXX Laboratories (IDXX) | United States | $51.473B | 49.32 |
| Alcon (ALC) | Switzerland | $38.991B | 26.28 |
| IQVIA Holdings (IQV) | United States | $31.930B | 17.25 |
| Mettler-Toledo (MTD) | United States | $28.059B | 32.10 |
| DexCom (DXCM) | United States | $27.289B | 37.62 |
| STERIS (STE) | Ireland | $24.749B | 25.02 |
| Waters (WAT) | United States | $22.705B | 30.02 |
| Coloplast (CLPBY) | Denmark | $17.601B | 26.93 |
| Hologic (HOLX) | United States | $16.701B | 17.48 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.912B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.959B | 11.58 |
| Penumbra (PEN) | United States | $13.355B | 93.94 |
| Globus Medical (GMED) | United States | $11.752B | 24.67 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.474B | 23.95 |
| Glaukos (GKOS) | United States | $6.463B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.024B | 19.14 |
| Teleflex (TFX) | United States | $4.792B | 7.64 |
| TransMedics (TMDX) | United States | $4.616B | 54.68 |
| LivaNova (LIVN) | United Kingdom | $3.635B | 19.63 |
| Integer Holdings (ITGR) | United States | $3.029B | 14.22 |
| Veracyte (VCYT) | United States | $2.861B | 32.60 |
| Elekta AB (EKTAY) | Sweden | $2.241B | 20.97 |
| UFP Technologies (UFPT) | United States | $2.062B | 27.22 |
| Alphatec Holdings (ATEC) | United States | $2.053B | 0.00 |
| Artivion (AORT) | United States | $1.876B | 86.07 |
| Nihon Kohden (NHNKY) | Japan | $1.855B | 20.47 |
| AxoGen (AXGN) | United States | $1.611B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.606B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.406B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.300B | 0.00 |
| IRadimed (IRMD) | United States | $1.221B | 58.16 |
| OPKO Health (OPK) | United States | $0.952B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.877B | 4.75 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.677B | 13.51 |
| SiBone (SIBN) | United States | $0.676B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.623B | 36.25 |
| Alpha Tau Medical (DRTS) | Israel | $0.603B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.576B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.549B | 0.00 |
| NeuroPace (NPCE) | United States | $0.522B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.515B | 13.42 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.507B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.435B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.418B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.383B | 0.00 |
| RxSight (RXST) | United States | $0.345B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.331B | 55.12 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.310B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.226B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.177B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.168B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.160B | 0.00 |
| Inogen (INGN) | United States | $0.154B | 0.00 |
| LENSAR (LNSR) | United States | $0.144B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.118B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.118B | 0.00 |
| Hyperfine (HYPR) | United States | $0.107B | 0.00 |
| Neuronetics (STIM) | United States | $0.107B | 0.00 |
| Solana (HSDT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Accuray (ARAY) | United States | $0.070B | 0.00 |
| DarioHealth (DRIO) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.044B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Envoy Medical (COCH) | United States | $0.014B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |